364 related articles for article (PubMed ID: 33928072)
1. Gold Nanoparticles in Cancer Theranostics.
Gao Q; Zhang J; Gao J; Zhang Z; Zhu H; Wang D
Front Bioeng Biotechnol; 2021; 9():647905. PubMed ID: 33928072
[TBL] [Abstract][Full Text] [Related]
2. pH-responsive unimolecular micelle-gold nanoparticles-drug nanohybrid system for cancer theranostics.
Lin W; Yao N; Qian L; Zhang X; Chen Q; Wang J; Zhang L
Acta Biomater; 2017 Aug; 58():455-465. PubMed ID: 28583900
[TBL] [Abstract][Full Text] [Related]
3. Structural-Engineering Rationales of Gold Nanoparticles for Cancer Theranostics.
Chen W; Zhang S; Yu Y; Zhang H; He Q
Adv Mater; 2016 Oct; 28(39):8567-8585. PubMed ID: 27461909
[TBL] [Abstract][Full Text] [Related]
4. Tumor self-responsive upconversion nanomedicines for theranostic applications.
Xu J; Gulzar A; Yang D; Gai S; He F; Yang P
Nanoscale; 2019 Oct; 11(38):17535-17556. PubMed ID: 31553008
[TBL] [Abstract][Full Text] [Related]
5. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles.
Cabral RM; Baptista PV
Expert Rev Mol Diagn; 2014 Nov; 14(8):1041-52. PubMed ID: 25314939
[TBL] [Abstract][Full Text] [Related]
7. Current state and prospects of the phytosynthesized colloidal gold nanoparticles and their applications in cancer theranostics.
Ovais M; Raza A; Naz S; Islam NU; Khalil AT; Ali S; Khan MA; Shinwari ZK
Appl Microbiol Biotechnol; 2017 May; 101(9):3551-3565. PubMed ID: 28382454
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticle decorated pH-sensitive polymeric nanocontainers as a potential theranostic agent.
Theodosiou M; Boukos N; Sakellis E; Zachariadis M; Efthimiadou EK
Colloids Surf B Biointerfaces; 2019 Nov; 183():110420. PubMed ID: 31421401
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
Sia CS; Lim HP; Tey BT; Goh BH; Low LE
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
[TBL] [Abstract][Full Text] [Related]
10. A novel gold-based stimuli-responsive theranostic nanomedicine for chemo-photothermal therapy of solid tumors.
Mahmoodzadeh F; Abbasian M; Jaymand M; Salehi R; Bagherzadeh-Khajehmarjan E
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():880-889. PubMed ID: 30274125
[TBL] [Abstract][Full Text] [Related]
11. Research perspectives: gold nanoparticles in cancer theranostics.
Li J; Gupta S; Li C
Quant Imaging Med Surg; 2013 Dec; 3(6):284-91. PubMed ID: 24404441
[TBL] [Abstract][Full Text] [Related]
12. Designing Stimuli-Responsive Upconversion Nanoparticles that Exploit the Tumor Microenvironment.
Ovais M; Mukherjee S; Pramanik A; Das D; Mukherjee A; Raza A; Chen C
Adv Mater; 2020 Jun; 32(22):e2000055. PubMed ID: 32227413
[TBL] [Abstract][Full Text] [Related]
13. Gold Cube-in-Cube Based Oxygen Nanogenerator: A Theranostic Nanoplatform for Modulating Tumor Microenvironment for Precise Chemo-Phototherapy and Multimodal Imaging.
Zhang X; Xi Z; Machuki JO; Luo J; Yang D; Li J; Cai W; Yang Y; Zhang L; Tian J; Guo K; Yu Y; Gao F
ACS Nano; 2019 May; 13(5):5306-5325. PubMed ID: 31018094
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy.
Lin H; Chen Y; Shi J
Chem Soc Rev; 2018 Mar; 47(6):1938-1958. PubMed ID: 29417106
[TBL] [Abstract][Full Text] [Related]
15. Surface Modification of Gold Nanoparticles with Small Molecules for Biochemical Analysis.
Chen Y; Xianyu Y; Jiang X
Acc Chem Res; 2017 Feb; 50(2):310-319. PubMed ID: 28068053
[TBL] [Abstract][Full Text] [Related]
16. Smart pH-sensitive micelles based on redox degradable polymers as DOX/GNPs carriers for controlled drug release and CT imaging.
Xiong D; Zhang X; Peng S; Gu H; Zhang L
Colloids Surf B Biointerfaces; 2018 Mar; 163():29-40. PubMed ID: 29278801
[TBL] [Abstract][Full Text] [Related]
17. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
[TBL] [Abstract][Full Text] [Related]
18. Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics.
Khan MA; Singh D; Ahmad A; Siddique HR
Eur J Pharm Sci; 2021 Sep; 164():105892. PubMed ID: 34052295
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cellular uptake and phototoxicity of Verteporfin-conjugated gold nanoparticles as theranostic nanocarriers for targeted photodynamic therapy and imaging of cancers.
Zhao L; Kim TH; Kim HW; Ahn JC; Kim SY
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():611-622. PubMed ID: 27287160
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances of Gold Nanoparticles in Biomedical Applications: State of the Art.
Aminabad NS; Farshbaf M; Akbarzadeh A
Cell Biochem Biophys; 2019 Jun; 77(2):123-137. PubMed ID: 30570696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
